MacQueen D, Minassian A, Kenton J, Geyer M, Perry W, Brigman J
Neuropharmacology. 2018; 138:87-96.
PMID: 29859849
PMC: 6340711.
DOI: 10.1016/j.neuropharm.2018.05.034.
Haubert A, Walsh M, Boyd R, Morris M, Wiedbusch M, Krusmark M
Front Psychol. 2018; 9:237.
PMID: 29559936
PMC: 5845631.
DOI: 10.3389/fpsyg.2018.00237.
MacQueen D, Minassian A, Henry B, Geyer M, Young J, Perry W
J Int Neuropsychol Soc. 2017; 24(3):283-293.
PMID: 29032769
PMC: 5820221.
DOI: 10.1017/S135561771700090X.
Del Campo N, Fryer T, Hong Y, Smith R, Brichard L, Acosta-Cabronero J
Brain. 2013; 136(Pt 11):3252-70.
PMID: 24163364
PMC: 4125626.
DOI: 10.1093/brain/awt263.
Lakhan S, Kirchgessner A
Brain Behav. 2012; 2(5):661-77.
PMID: 23139911
PMC: 3489818.
DOI: 10.1002/brb3.78.
Methylphenidate modulates sustained attention and cortical activation in survivors of traumatic brain injury: a perfusion fMRI study.
Kim J, Whyte J, Patel S, Europa E, Wang J, Coslett H
Psychopharmacology (Berl). 2011; 222(1):47-57.
PMID: 22203319
PMC: 3369011.
DOI: 10.1007/s00213-011-2622-8.
Are prescription stimulants "smart pills"? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals.
Smith M, Farah M
Psychol Bull. 2011; 137(5):717-41.
PMID: 21859174
PMC: 3591814.
DOI: 10.1037/a0023825.
Animal models to guide clinical drug development in ADHD: lost in translation?.
Wickens J, Hyland B, Tripp G
Br J Pharmacol. 2011; 164(4):1107-28.
PMID: 21480864
PMC: 3229754.
DOI: 10.1111/j.1476-5381.2011.01412.x.
Effects of modafinil and methylphenidate on visual attention capacity: a TVA-based study.
Finke K, Dodds C, Bublak P, Regenthal R, Baumann F, Manly T
Psychopharmacology (Berl). 2010; 210(3):317-29.
PMID: 20352415
DOI: 10.1007/s00213-010-1823-x.
Life in the last lane.
Grant J
Paediatr Child Health. 2010; 7(10):681-8.
PMID: 20046449
PMC: 2796529.
The 5-choice continuous performance test: evidence for a translational test of vigilance for mice.
Young J, Light G, Marston H, Sharp R, Geyer M
PLoS One. 2009; 4(1):e4227.
PMID: 19156216
PMC: 2626630.
DOI: 10.1371/journal.pone.0004227.
Vigilance, alertness, or sustained attention: physiological basis and measurement.
Oken B, Salinsky M, Elsas S
Clin Neurophysiol. 2006; 117(9):1885-901.
PMID: 16581292
PMC: 2865224.
DOI: 10.1016/j.clinph.2006.01.017.
Methylphenidate increases cortical excitability via activation of alpha-2 noradrenergic receptors.
Andrews G, Lavin A
Neuropsychopharmacology. 2005; 31(3):594-601.
PMID: 15999146
PMC: 5509071.
DOI: 10.1038/sj.npp.1300818.
Methylphenidate does not modify the impact of response frequency or stimulus sequence on performance and event-related potentials of children with attention deficit hyperactivity disorder.
Smithee J, Klorman R, Brumaghim J, Borgstedt A
J Abnorm Child Psychol. 1998; 26(4):233-45.
PMID: 9700516
DOI: 10.1023/a:1022698232481.
Does haloperidol block methylphenidate? Motivation or attention?.
Levy F, Hobbes G
Psychopharmacology (Berl). 1996; 126(1):70-4.
PMID: 8853219
DOI: 10.1007/BF02246413.
Cognitive effects of milacemide and methylphenidate in healthy young adults.
HERTING R
Psychopharmacology (Berl). 1994; 115(1-2):46-52.
PMID: 7862911
DOI: 10.1007/BF02244750.
Methylphenidate influences on both early and late ERP waves of ADHD children in a continuous performance test.
Verbaten M, Overtoom C, Koelega H, Swaab-Barneveld H, Van der Gaag R, Buitelaar J
J Abnorm Child Psychol. 1994; 22(5):561-78.
PMID: 7822629
DOI: 10.1007/BF02168938.
Information processing components of the auditory event related potential are reduced by cocaine.
Herning R, Jones R, Hooker W, Tulunay F
Psychopharmacology (Berl). 1985; 87(2):178-85.
PMID: 3931143
DOI: 10.1007/BF00431804.
Detection of benzodiazepine receptor occupancy in the human brain by positron emission tomography.
Shinotoh H, Iyo M, Yamada T, Inoue O, Suzuki K, Itoh T
Psychopharmacology (Berl). 1989; 99(2):202-7.
PMID: 2552484
DOI: 10.1007/BF00442808.
